IMVT
Immunovant·NASDAQ
--
--(--)
--
--(--)
7.02 / 10
Outperform
Sentiment scores 7.02 (Outperform) and fund‑flow 7.83 (good), driven by strong Large‑cap inflows but negative trends in other sizes. Two analysts issue Strong Buy recommendations, yielding a weighted rating of 6.21. Insider sold ~2.9k shares; price fell 4.08%.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-10
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for IMVT?
- IMVT holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.02/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
